The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Will The Market Value Of The Hematocrit Test Devices Market Progress Between 2026 And 2030?
The market for hematocrit test devices has demonstrated strong growth in recent years. It is anticipated to expand from $4.91 billion in 2025 to $5.22 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.4%. This historic growth can be attributed to the increasing prevalence of anemia and blood disorders, an uptick in hospital and laboratory diagnostic testing, a rising demand for blood donor screening, the expansion of emergency and trauma care services, and a growing awareness of hematocrit monitoring in clinical practice.
The hematocrit test devices market size is projected to experience robust expansion over the coming years. It is anticipated to reach $6.47 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.5%. Factors contributing to this growth during the forecast period include the escalating demand for point-of-care diagnostics, the rising prevalence of chronic and lifestyle-related illnesses, the expansion of decentralized healthcare and home testing solutions, increasing investments in diagnostic infrastructure, and a heightened emphasis on early disease detection and preventive healthcare. Key trends observed within the forecast period encompass the increasing uptake of point-of-care hematocrit testing devices, a growing need for swift and precise blood parameter evaluation, the expanding utilization of portable and handheld hematocrit meters, the broadening application of hematocrit testing in emergency and critical care environments, and a reinforced emphasis on routine screening and ongoing management of chronic diseases.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15582&type=smp
What Key Drivers Are Fueling The Growth Of The Hematocrit Test Devices Market?
The rising prevalence of blood disorders is anticipated to boost the growth of the hematocrit test devices market moving forward. A blood disorder describes a condition that impacts human blood components, including red blood cells, white blood cells, platelets, and blood plasma. The growing commonality of blood disorders is linked to several factors, such as genetic predispositions, environmental pollution, and shifts in lifestyle. Hematocrit test devices are primarily utilized to determine the volume percentage of red blood cells in whole blood, providing crucial information regarding a patient’s hematological health. For instance, in January 2024, a report from the American Cancer Society, a US-based non-profit organization, indicated that approximately 62,770 new cases of leukemia across all types are projected in the United States in 2024, leading to an estimated 23,670 deaths. Among these cases, around 20,800 new instances of acute myeloid leukemia (AML) are expected, predominantly affecting adults, with approximately 11,220 deaths attributed to AML, nearly exclusively among adult patients. Therefore, the increasing occurrences of blood disorders are driving the expansion of the hematocrit test devices market.
What Segment Categories Shape The Hematocrit Test Devices Market Segment Landscape?
The hematocrit test devices market covered in this report is segmented –
1) By Product: Hematocrit Test Meter, Hematocrit Test Analyzer, Reagents And Consumables
2) By Application: Anemia, Polycythemia Vera, Congenital Heart Diseases, Other Applications
3) By End-User: Hospitals And Ambulatory Surgical Centers, Clinics, Diagnostic And Pathology Labs, Other End-Users
Subsegments:
1) By Hematocrit Test Meter: Handheld Hematocrit Meters, Portable Hematocrit Meters, Desktop Hematocrit Meters, Point-Of-Care Hematocrit Meters, Digital Hematocrit Meters, Battery-Powered Hematocrit Meters
2) By Hematocrit Test Analyzer: Automated Hematocrit Analyzers, Benchtop Hematocrit Analyzers, Semi-Automated Hematocrit Analyzers, Microhematocrit Analyzers, High-Throughput Hematocrit Analyzers, Compact Hematocrit Analyzers
3) By Reagents And Consumables: Hematocrit Test Strips, Hematocrit Pipettes And Capillaries, Blood Sample Collection Tubes For Hematocrit Testing, Quality Control Reagents For Hematocrit Testing, Calibration Standards For Hematocrit Devices, Disposable Test Kits And Consumables
What Trends Are Influencing The Hematocrit Test Devices Market?
Leading enterprises within the hematocrit test device market are prioritizing cutting-edge technologies, particularly user-friendly platforms tailored for laboratories with moderate testing volumes. Such platforms are systems designed with straightforward, intuitive features that enable rapid operation with minimal prior instruction. For instance, in March 2024, Mindray, a health technology firm based in China, unveiled the BC-700 Series—a streamlined, all-in-one hematology analyzer suitable for small to medium-sized laboratories. This device integrates both CBC and ESR testing, providing results in a mere 1.5 minutes, thereby enhancing operational efficiency and workflow. It incorporates SF Cube 3D analysis technology for precise cell differentiation and features the PLT-H parameter to improve platelet count accuracy. By merging CBC and ESR into a single unit, it helps reduce expenses related to equipment and consumables. Offered in both open vial and autoloader configurations, the BC-700 Series ensures dependable, automated, and compact testing solutions, exhibiting a strong correlation with conventional methodologies, alongside improved safety and repeatability.
Who Are The Companies Operating Across The Hematocrit Test Devices Market Value Chain?
Major companies operating in the hematocrit test devices market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare GmbH, Becton Dickinson and Company, Terumo Corporation, Beckman Coulter Inc., Mindray Medical International Limited, bioMérieux SA, Sysmex Corporation, Horiba Ltd., Nihon Kohden Corporation, Erba Mannheim, EKF Diagnostics Holding Plc., Nova Biomedical Corporation, Boule Diagnostics AB, Stanbio Laboratory LP, Drucker Diagnostics, A. Menarini Diagnostics Srl, Sensa Core, Mikroscan Technologies Inc.
Get The Full Hematocrit Test Devices Market Report:
https://www.thebusinessresearchcompany.com/report/hematocrit-test-devices-global-market-report
Which Region Leads The Hematocrit Test Devices Market In Overall Market Size?
North America was the largest region in the hematocrit test devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hematocrit test devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Hematocrit Test Devices Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=15582&type=smp
Browse Through More Reports Similar to the Global Hematocrit Test Devices Market 2026, By The Business Research Company
Hematology Diagnostic Devices And Equipment Market Report 2026
Dermatological Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/dermatological-drugs-global-market-report
Hemato Oncology Testing Market Report 2026
https://www.thebusinessresearchcompany.com/report/hemato-oncology-testing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model